OBM Transplantation (ISSN 2577-5820) is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc., which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.

OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.

We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor. 


Publication Speed (median values for papers published in 2023): Submission to First Decision: 6.7 weeks; Submission to Acceptance: 14.4 weeks; Acceptance to Publication: 6 days (1-2 days of FREE language polishing included)

Current Issue: 2024  Archive: 2023 2022 2021 2020 2019 2018 2017

Special Issue

Research on Xenotransplantation

Submission Deadline: November 30, 2021 (Open) Submit Now

Guest Editor

Suzanne Bertera, PhD

Institute of Cellular Therapeutics, Allegheny-Singer Research Institute, Allegheny Health Network, South Tower, 320 East North Avenue, Pittsburgh, PA 15212-4772, USA

Tel: 412-359-4758

Website | E-Mail

Research Interests: Diabetes research; islet isolation and transplantation; islet xenotransplantation; cell transplantation; gene therapy

About This Topic

This special issue focuses on xenotransplantation of tissues, cells, and organs. Xenotransplantation is widely seen as one of the options available to narrow the gap between human organ donors and demand for organs for transplantation. Advancements in understanding the mechanisms of xeno-rejection, improved immunosuppressive options, and easier methods of genetic manipulation of potential pig organ donors have helped bring xenotransplantation from the realm of science fiction to the dawn of a clinical age. Pig tissues such as heart valves are already transplanted into patients, clinical trials of porcine corneas and islet cells have been undertaken, and preliminary data suggests the first clinical trials of kidney and heart may soon begin. Authors are invited to submit reviews and commentaries or original data for peer review. This issue is intended as a single source to provide up to date knowledge and opinion on xenotransplantation. Topics may include the advantages and limitations of using various animal models, preliminary data on organ or cellular cross-species transplantation, immunology, methods of animal cloning or genetic manipulation, public opinion and ethics of xenotransplantation, or any topic relevant to the field.

Manuscript Submission Information

Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (transplantation@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.

Welcome your submission!